While Aurobindo Pharma has committed an investment of Rs 3,039 crore to set up production facilities for three eligible products, Kinvan will invest Rs 447.17 crore to build 300 MT capacity plant to produce Clavulanic Acid

According to the World Health Organisation (WHO), super gonorrhea may become drug-resistant, including resistance to recommended treatments such as azithromycin, which has seen an increase in its usage during the coronavirus pandemic

The World Health Organisation clearly states the sexually transmitted infection (STI) may become even more resistant to the recommended treatments like azithromycin

Tech spend is expected to increase to $2.9 trillion by 2021. We are looking at a seismic shift in the scaling of digitization at a pace never seen before, said Rakesh Rathi

Initially being admitted to a hospital in Delhi, he had to be put on ECMO support owing to severe damages to his lungs. With the Pulmonary Fibrosis worsening and the infection seeping into his bloodstream, the transplant had become paramount to save the patient's life.

Entire controversy around the so-called 'honeygate' was triggered after the research and advocacy firm CSE in its recent report said 10 among top brands like Dabur, Patanjali, Baidyanath, Zandu, Hitkari and Apis Himalaya are allegedly adulterated with sugar syrup

Eat Just said on December 2, that its cultured chicken has been given \"first-in-the-world regulatory approval\" by Singapore's authorities

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

FreshToHome (FTH), a fully integrated e-commerce fish and meat brand, raised $121 million, the largest ever series C stage funding deal in the e-commerce space

COVID-19 impact: Indian economy to shrink 10.3% in FY21, says IMFIndian economy will contract 10.3 per cent in the financial year 2020-21 as the country gradually climbs out of the coronavirus-induced lockdown, said the International Monetary Fund in its Wold Economic Outlook report released on Tuesday. This projection is substantially lower than the 4.5 per cent de-growth predicted by the internatonal financial instutution back in June, indicating challenges to economic growth as the pandem...

The trade deficit between India and China from April-August stands at $12.6 billion as compared to $22.6 billion in April-August period of FY20. In FY19, this was $23.5 billion and $26.33 billion in FY18

China's imports from India have gone up 6.7 per cent since January this year to $11.09 billion. As a result, total trade with India has registered a slightly lower 18.6 per cent drop since the beginning of 2020

As part of the new project, Indian and British experts will sample and model two contrasting river networks in India the Musi river in Hyderabad, which has high concentrations of antibiotics released from production facilities, and the less polluted Adyar river in Chennai

Currently, India imports 68 per cent APIs and more than 90 per cent antibiotics from China. the country's pharmaceutical industry is the world's third-largest in terms of volume

Profit-driven enterprises are ill-suited to protect the health and life of a vast majority of people, as the US and Indian governments experience, but do precious little, thereby failing in their primary duty

Coronavirus myths: Thanks to the potent combination of social media and mischief-makers, there are an endless number of myths floating around on COVID-19

Earlier, it had advised all COVID-19 hospitals to opt for \"prone awake ventilation\" as and when possible before putting a patient on conventional mechanical ventilation

\"Remdesavir seems to be useful for those who are coping with the beginning part of the disease and dexamethasone is useful for those who have to deal with the disease in its later phase within the body\"

Indian companies are dependent on China for all the key ingredients made using the fermentation process, where China has achieved global dominance and capacities

What is more interesting is that the incentive - reimbursement of 10 to 20 percent of the net incremental sales turnover for the first four years, depending on the category you fall - will be calculated only on the revenue earned from domestic sales with a ceiling on the quantity that can be sold